Skip to main content
Top
Published in: Diabetologia 3/2009

01-03-2009 | Article

Complexity of factors related to outcome of neuropathic and neuroischaemic/ischaemic diabetic foot ulcers: a cohort study

Authors: M. A. Gershater, M. Löndahl, P. Nyberg, J. Larsson, J. Thörne, M. Eneroth, J. Apelqvist

Published in: Diabetologia | Issue 3/2009

Login to get access

Abstract

Aims/hypothesis

We sought to identify factors related to short-term outcome of foot ulcers in patients with diabetes treated in a multidisciplinary system until healing was achieved.

Methods

Consecutively presenting patients with diabetes and worst foot ulcer (Wagner grade 1–5, below ankle) (n = 2,511) were prospectively followed and treated according to a standardised protocol until healing was achieved or until death. The number of patients lost to dropout was 31. The characteristics of the remaining 2,480 patients were: 1,465 men, age 68 ± 15 years (range 18–96), type 1 diabetes 18%, type 2 diabetes 82% and insulin-treated 62%.

Results

The healing rate without major amputation in surviving patients was 90.6% (n = 1,867). Sixty-five per cent (n = 1,617) were healed primarily, 9% (n = 250) after minor amputation and 8% after major amputation; 17% (n = 420) died unhealed. Out of 2,060 surviving patients, 1,007 were neuroischaemic (48.8%). In a multiple regression analysis, primary healing was related to co-morbidity, duration of diabetes, extent of peripheral vascular disease and type of ulcer. In neuropathic ulcers, deep foot infection, site of ulcer and co-morbidity were related to amputation. Amputation in neuroischaemic ulcers was related to co-morbidity, peripheral vascular disease and type of ulcer. Age, sex, duration of diabetes, neuropathy, deformity and duration of ulcer or site of ulcer did not have an evident influence on probability of amputation.

Conclusions/interpretation

Patients with diabetic foot ulcer suffer from multi-organ disease. Factors related to outcome are correspondingly complex.
Literature
1.
go back to reference Boulton AJM, Vileikyte L, Ragnarson-Tennvall G, Apelqvist J (2005) The global burden of diabetic foot disease. Lancet 366:1719–1724PubMedCrossRef Boulton AJM, Vileikyte L, Ragnarson-Tennvall G, Apelqvist J (2005) The global burden of diabetic foot disease. Lancet 366:1719–1724PubMedCrossRef
2.
go back to reference International Working Group on the Diabetic Foot/Consultative Section of the IDF (2007) Practical guidelines in the management and the prevention of the diabetic foot, based upon the International Consensus on the Diabetic Foot (DVD) International Working Group on the Diabetic Foot/Consultative Section of the IDF (2007) Practical guidelines in the management and the prevention of the diabetic foot, based upon the International Consensus on the Diabetic Foot (DVD)
3.
go back to reference Larsson J, Agardh CD, Apelqvist J, Stenström A (1998) Long-term prognosis after healed amputation in patients with diabetes. Clin Orthop Relat Res 350:149–158PubMedCrossRef Larsson J, Agardh CD, Apelqvist J, Stenström A (1998) Long-term prognosis after healed amputation in patients with diabetes. Clin Orthop Relat Res 350:149–158PubMedCrossRef
4.
go back to reference Jeffcoate WJ, Chipchase SY, Ince P, Game FL (2006) Assessing the outcome of the management of diabetic foot ulcers using ulcer-related and person-related measures. Diabetes Care 29:1784–1787PubMedCrossRef Jeffcoate WJ, Chipchase SY, Ince P, Game FL (2006) Assessing the outcome of the management of diabetic foot ulcers using ulcer-related and person-related measures. Diabetes Care 29:1784–1787PubMedCrossRef
5.
go back to reference Singh N, Armstrong DG, Lipsky BA (2005) Preventing foot ulcers in patients with diabetes. JAMA 293:217–228PubMedCrossRef Singh N, Armstrong DG, Lipsky BA (2005) Preventing foot ulcers in patients with diabetes. JAMA 293:217–228PubMedCrossRef
6.
go back to reference Apelqvist J (2007) Diabetic foot ulcers: Evidence, cost and management. Diabet Foot J 10:6–8 Apelqvist J (2007) Diabetic foot ulcers: Evidence, cost and management. Diabet Foot J 10:6–8
7.
go back to reference Wagner FW (1981) The dysvascular foot: a system for diagnosis and treatment. Foot Ankle 2:64–122PubMed Wagner FW (1981) The dysvascular foot: a system for diagnosis and treatment. Foot Ankle 2:64–122PubMed
8.
go back to reference Apelqvist J, Castenfors J, Larsson J, Stenström A, Agardh C (1989) Wound classification is more important than site of ulceration in the outcome of diabetic foot ulcers. Diabet Med 6:526–530PubMed Apelqvist J, Castenfors J, Larsson J, Stenström A, Agardh C (1989) Wound classification is more important than site of ulceration in the outcome of diabetic foot ulcers. Diabet Med 6:526–530PubMed
9.
go back to reference Apelqvist J, Agardh CD (1992) The association between clinical risk factors and outcome of diabetic foot ulcers. Diabetes Res Clin Pract 18:43–53PubMedCrossRef Apelqvist J, Agardh CD (1992) The association between clinical risk factors and outcome of diabetic foot ulcers. Diabetes Res Clin Pract 18:43–53PubMedCrossRef
10.
go back to reference Colwell JA, Bingham SF, Abraira C, Anderson JW, Kwaan HC (1985) V.A. Cooperative Study on antiplatelet agents in diabetic patients after amputation for gangrene: III. Definitions and review of design and baseline characteristics. Horm Metab Res Suppl 15:69–73PubMedCrossRef Colwell JA, Bingham SF, Abraira C, Anderson JW, Kwaan HC (1985) V.A. Cooperative Study on antiplatelet agents in diabetic patients after amputation for gangrene: III. Definitions and review of design and baseline characteristics. Horm Metab Res Suppl 15:69–73PubMedCrossRef
11.
go back to reference Boulton A, Connor H, Cavanagh PR (eds) (2000) The foot in diabetes. Wiley, Chichester Boulton A, Connor H, Cavanagh PR (eds) (2000) The foot in diabetes. Wiley, Chichester
12.
go back to reference Cannon J (1965) Intermittent claudication what it is and isn’t. Calif Med 102:301–305PubMed Cannon J (1965) Intermittent claudication what it is and isn’t. Calif Med 102:301–305PubMed
13.
go back to reference Apelqvist J, Castenfors J, Stenström A, Agardh C (1989) Prognostic value of systolic ankle and toe pressure levels in outcome of diabetic foot ulcer. Diabetes Care 12:373–378PubMedCrossRef Apelqvist J, Castenfors J, Stenström A, Agardh C (1989) Prognostic value of systolic ankle and toe pressure levels in outcome of diabetic foot ulcer. Diabetes Care 12:373–378PubMedCrossRef
14.
go back to reference Eneroth M, Larsson J, Oscarsson C, Apelqvist J (2004) Nutritional supplementation for diabetic foot ulcers: the first RCT. J Wound Care 13:230–234PubMed Eneroth M, Larsson J, Oscarsson C, Apelqvist J (2004) Nutritional supplementation for diabetic foot ulcers: the first RCT. J Wound Care 13:230–234PubMed
15.
go back to reference Eneroth M, Larsson J, Apelqvist J (1999/0) Deep foot infections in patients with diabetes and foot ulcer: an entity with different characteristics, treatments, and prognosis. J Diabetes Its Complicat 13:254–263CrossRef Eneroth M, Larsson J, Apelqvist J (1999/0) Deep foot infections in patients with diabetes and foot ulcer: an entity with different characteristics, treatments, and prognosis. J Diabetes Its Complicat 13:254–263CrossRef
16.
go back to reference Larsson J, Agardh C, Apelqvist J, Stenström A (1995) Clinical characteristics in relation to final amputation level in diabetic patients with foot ulcers: a prospective study of healing below or above the ankle in 187 patients. Foot Ankle 16:69–74PubMed Larsson J, Agardh C, Apelqvist J, Stenström A (1995) Clinical characteristics in relation to final amputation level in diabetic patients with foot ulcers: a prospective study of healing below or above the ankle in 187 patients. Foot Ankle 16:69–74PubMed
17.
go back to reference Moore DS, McCabe GP (2006) Introduction to the practice of statistics. Freeman, New York Moore DS, McCabe GP (2006) Introduction to the practice of statistics. Freeman, New York
18.
go back to reference Oyibo SO, Jude EB, Tarawneh I et al (2001) The effects of ulcer size and site, patient’s age, sex and type and duration of diabetes on the outcome of diabetic foot ulcers. Diabet Med 18:133–138PubMedCrossRef Oyibo SO, Jude EB, Tarawneh I et al (2001) The effects of ulcer size and site, patient’s age, sex and type and duration of diabetes on the outcome of diabetic foot ulcers. Diabet Med 18:133–138PubMedCrossRef
19.
go back to reference Gul A, Basit A, Ali SM, Ahmadani MY, Miyan Z (2006) Role of wound classicifation in predicting the outcome of diabetic foot ulcer. J Pak Med Assoc 56:444–447PubMed Gul A, Basit A, Ali SM, Ahmadani MY, Miyan Z (2006) Role of wound classicifation in predicting the outcome of diabetic foot ulcer. J Pak Med Assoc 56:444–447PubMed
20.
go back to reference Prompers L, Schaper N, Apelqvist J et al (2008) Prediction of outcome in individuals with diabetic foot ulcers: focus on the differences between individuals with and without peripheral arterial disease. The Eurodiale study. Diabetologia 51:747–755PubMedCrossRef Prompers L, Schaper N, Apelqvist J et al (2008) Prediction of outcome in individuals with diabetic foot ulcers: focus on the differences between individuals with and without peripheral arterial disease. The Eurodiale study. Diabetologia 51:747–755PubMedCrossRef
21.
go back to reference Beckert S, Witte M, Wicke C, Konigsrainer A, Coerper S (2006) A new wound-based severity score for diabetic foot ulcers: a prospective analysis of 1,000 patients. Diabetes Care 29:988–992PubMedCrossRef Beckert S, Witte M, Wicke C, Konigsrainer A, Coerper S (2006) A new wound-based severity score for diabetic foot ulcers: a prospective analysis of 1,000 patients. Diabetes Care 29:988–992PubMedCrossRef
22.
go back to reference Margolis DJ, Allen-Taylor L, Hoffstad O, Berlin JA (2002) Diabetic neuropathic foot ulcers: the association of wound size, wound duration, and wound grade on healing. Diabetes Care 25:1835–1839PubMedCrossRef Margolis DJ, Allen-Taylor L, Hoffstad O, Berlin JA (2002) Diabetic neuropathic foot ulcers: the association of wound size, wound duration, and wound grade on healing. Diabetes Care 25:1835–1839PubMedCrossRef
23.
go back to reference Apelqvist J, Larsson J, Agardh C (1993) Long-term prognosis for diabetic patients with foot ulcers. J Intern Med 233:485–491PubMed Apelqvist J, Larsson J, Agardh C (1993) Long-term prognosis for diabetic patients with foot ulcers. J Intern Med 233:485–491PubMed
24.
go back to reference Prompers L, Huijberts M, Apelqvist J et al (2007) High prevalence of ischaemia, infection and serious comorbidity in patients with diabetic foot disease in Europe. Baseline results from the Eurodiale Study. Diabetologia 50:18–25PubMedCrossRef Prompers L, Huijberts M, Apelqvist J et al (2007) High prevalence of ischaemia, infection and serious comorbidity in patients with diabetic foot disease in Europe. Baseline results from the Eurodiale Study. Diabetologia 50:18–25PubMedCrossRef
25.
go back to reference Boyko EJ, Ahroni JH, Cohen V, Nelson KM, Heagerty PJ (2006) Prediction of diabetic foot ulcer occurrence using commonly available clinical information: the Seattle diabetic foot study. Diabetes Care 29:1202–1207PubMedCrossRef Boyko EJ, Ahroni JH, Cohen V, Nelson KM, Heagerty PJ (2006) Prediction of diabetic foot ulcer occurrence using commonly available clinical information: the Seattle diabetic foot study. Diabetes Care 29:1202–1207PubMedCrossRef
26.
go back to reference Margolis DJ, Kantor J, Santanna J, Strom BL, Berlin JA (2000) Risk factors for delayed healing of neuropathic diabetic foot ulcers: a pooled analysis. Arch Dermatol 136:1531–1535PubMedCrossRef Margolis DJ, Kantor J, Santanna J, Strom BL, Berlin JA (2000) Risk factors for delayed healing of neuropathic diabetic foot ulcers: a pooled analysis. Arch Dermatol 136:1531–1535PubMedCrossRef
27.
go back to reference Sheehan P, Jones P, Caselli A, Giurini JM, Veves A (2003) Percent change in wound area of diabetic foot ulcers over a 4-week period is a robust predictor of complete healing in a 12-week prospective trial. Diabetes Care 26:1879–1882PubMedCrossRef Sheehan P, Jones P, Caselli A, Giurini JM, Veves A (2003) Percent change in wound area of diabetic foot ulcers over a 4-week period is a robust predictor of complete healing in a 12-week prospective trial. Diabetes Care 26:1879–1882PubMedCrossRef
28.
go back to reference Bild DE, Selby JV, Sinnock P, Browner WS, Braveman P, Showstack JA (1989) Lower-extremity amputation in people with diabetes. Epidemiology and prevention. Diabetes Care 12:24–31PubMedCrossRef Bild DE, Selby JV, Sinnock P, Browner WS, Braveman P, Showstack JA (1989) Lower-extremity amputation in people with diabetes. Epidemiology and prevention. Diabetes Care 12:24–31PubMedCrossRef
29.
go back to reference Kreines K, Johnson E, Albrink M et al (1985) The course of peripheral vascular disease in non-insulin-dependent diabetes. Diabetes Care 8:235–243PubMedCrossRef Kreines K, Johnson E, Albrink M et al (1985) The course of peripheral vascular disease in non-insulin-dependent diabetes. Diabetes Care 8:235–243PubMedCrossRef
30.
go back to reference Edmonds M (1986) The diabetic foot: pathophysiology and treatment. Clin Endocrinol Metab 15:889–916PubMedCrossRef Edmonds M (1986) The diabetic foot: pathophysiology and treatment. Clin Endocrinol Metab 15:889–916PubMedCrossRef
31.
go back to reference Lavery LA, Armstrong DG, Wunderlich RP, Mohler MJ, Wendel CS, Lipsky BA (2006) Risk factors for foot infections in individuals with diabetes. Diabetes Care 29:1288–1293PubMedCrossRef Lavery LA, Armstrong DG, Wunderlich RP, Mohler MJ, Wendel CS, Lipsky BA (2006) Risk factors for foot infections in individuals with diabetes. Diabetes Care 29:1288–1293PubMedCrossRef
32.
go back to reference Pecoraro RE, Reiber GE, Burgess EM (1990) Pathways to diabetic limb amputation. Basis for prevention. Diabetes Care 13:513–521PubMedCrossRef Pecoraro RE, Reiber GE, Burgess EM (1990) Pathways to diabetic limb amputation. Basis for prevention. Diabetes Care 13:513–521PubMedCrossRef
33.
go back to reference Knighton DR, Fylling CP, Fiegel VD, Cerra F (1990) Amputation prevention in an independently reviewed at-risk diabetic population using a comprehensive wound care protocol. Am J Surg 160:466–471PubMedCrossRef Knighton DR, Fylling CP, Fiegel VD, Cerra F (1990) Amputation prevention in an independently reviewed at-risk diabetic population using a comprehensive wound care protocol. Am J Surg 160:466–471PubMedCrossRef
34.
go back to reference Lazzarini L, Lipsky BA, Mader JT (2005) Antibiotic treatment of osteomyelitis: what have we learned from 30 years of clinical trials? Int J Infect Dis 9:127–138PubMedCrossRef Lazzarini L, Lipsky BA, Mader JT (2005) Antibiotic treatment of osteomyelitis: what have we learned from 30 years of clinical trials? Int J Infect Dis 9:127–138PubMedCrossRef
35.
go back to reference Apelqvist J (2008) The foot in perspective. Diabetes/Metab Res Rev 24(Suppl 1):S110–S115CrossRef Apelqvist J (2008) The foot in perspective. Diabetes/Metab Res Rev 24(Suppl 1):S110–S115CrossRef
36.
go back to reference Edmonds M, Boulton A, Buckenham T et al (1996) Report of the diabetic foot and amputation group. Diabet Med 13:S27–S42PubMed Edmonds M, Boulton A, Buckenham T et al (1996) Report of the diabetic foot and amputation group. Diabet Med 13:S27–S42PubMed
37.
go back to reference Marston WA (2006) Risk factors associated with healing chronic diabetic foot ulcers: the importance of hyperglycaemia. Ostomy Wound Manage 52:26–28PubMed Marston WA (2006) Risk factors associated with healing chronic diabetic foot ulcers: the importance of hyperglycaemia. Ostomy Wound Manage 52:26–28PubMed
38.
go back to reference Beach KW, Strandness DEJ (1980) Arteriosclerosis obliterans and associated risk factors in insulin-dependent and non-insulin-dependent diabetes. Diabetes 29:882–888PubMedCrossRef Beach KW, Strandness DEJ (1980) Arteriosclerosis obliterans and associated risk factors in insulin-dependent and non-insulin-dependent diabetes. Diabetes 29:882–888PubMedCrossRef
39.
go back to reference Kuebler TW, Bendick PJ, Fineberg SE et al (1983) Diabetes mellitus and cerebrovascular disease: prevalence of carotid artery occlusive disease and associated risk factors in 482 adult diabetic patients. Diabetes Care 6:274–278PubMedCrossRef Kuebler TW, Bendick PJ, Fineberg SE et al (1983) Diabetes mellitus and cerebrovascular disease: prevalence of carotid artery occlusive disease and associated risk factors in 482 adult diabetic patients. Diabetes Care 6:274–278PubMedCrossRef
40.
go back to reference Nelson RG, Gohdes DM, Everhart JE et al (1988) Lower-extremity amputations in NIDDM. 12-yr follow-up study in Pima Indians. Diabetes Care 11:8–16PubMedCrossRef Nelson RG, Gohdes DM, Everhart JE et al (1988) Lower-extremity amputations in NIDDM. 12-yr follow-up study in Pima Indians. Diabetes Care 11:8–16PubMedCrossRef
41.
go back to reference Lindholm E, Melander O, Almgren P et al (2006) Polymorphism in the MHC2TA gene is associated with features of the metabolic syndrome and cardiovascular mortality. PLoS ONE 1(e64):1–5CrossRef Lindholm E, Melander O, Almgren P et al (2006) Polymorphism in the MHC2TA gene is associated with features of the metabolic syndrome and cardiovascular mortality. PLoS ONE 1(e64):1–5CrossRef
42.
go back to reference Tivesten Å, Mellström D, Jutberger H et al (2007) Low serum testosterone and high serum estradiol associate with lower extremity peripheral arterial disease in elderly men: the MrOS Study in Sweden. J Am Coll Cardiol 50:1070–1076PubMedCrossRef Tivesten Å, Mellström D, Jutberger H et al (2007) Low serum testosterone and high serum estradiol associate with lower extremity peripheral arterial disease in elderly men: the MrOS Study in Sweden. J Am Coll Cardiol 50:1070–1076PubMedCrossRef
43.
go back to reference Hjelm K, Nyberg P, Apelqvist J (2002) Gender influences beliefs about health and illness in diabetic subjects with severe foot lesions. J Adv Nurs 40:673–684PubMedCrossRef Hjelm K, Nyberg P, Apelqvist J (2002) Gender influences beliefs about health and illness in diabetic subjects with severe foot lesions. J Adv Nurs 40:673–684PubMedCrossRef
45.
go back to reference Norlund A, Apelqvist J, Bitzén P, Nyberg P, Scherstén B (2001) Cost of illness of adult diabetes mellitus underestimated if comorbidity is not considered. J Intern Med 250:57–65PubMedCrossRef Norlund A, Apelqvist J, Bitzén P, Nyberg P, Scherstén B (2001) Cost of illness of adult diabetes mellitus underestimated if comorbidity is not considered. J Intern Med 250:57–65PubMedCrossRef
46.
go back to reference Apelqvist J, Larsson J (2000) What is the most effective way to reduce incidence of amputation in the diabetic foot? Diabetes Metab Res Rev 16:S75–S83PubMedCrossRef Apelqvist J, Larsson J (2000) What is the most effective way to reduce incidence of amputation in the diabetic foot? Diabetes Metab Res Rev 16:S75–S83PubMedCrossRef
Metadata
Title
Complexity of factors related to outcome of neuropathic and neuroischaemic/ischaemic diabetic foot ulcers: a cohort study
Authors
M. A. Gershater
M. Löndahl
P. Nyberg
J. Larsson
J. Thörne
M. Eneroth
J. Apelqvist
Publication date
01-03-2009
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 3/2009
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-008-1226-2

Other articles of this Issue 3/2009

Diabetologia 3/2009 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.